IN2014DN01468A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN01468A IN2014DN01468A IN1468DEN2014A IN2014DN01468A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A IN 1468DEN2014 A IN1468DEN2014 A IN 1468DEN2014A IN 2014DN01468 A IN2014DN01468 A IN 2014DN01468A
- Authority
- IN
- India
- Prior art keywords
- oligosaccharide
- composition
- infants
- mixture
- probiotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11185600 | 2011-10-18 | ||
| PCT/EP2012/070281 WO2013057049A1 (fr) | 2011-10-18 | 2012-10-12 | Composition destinée à être utilisée pour la croissance du cerveau et/ou le développement cognitif et/ou psychomoteur |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN01468A true IN2014DN01468A (fr) | 2015-05-22 |
Family
ID=47019022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1468DEN2014 IN2014DN01468A (fr) | 2011-10-18 | 2012-10-12 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20140271562A1 (fr) |
| EP (2) | EP3095331A1 (fr) |
| CN (1) | CN103889238B (fr) |
| AU (1) | AU2012325060B2 (fr) |
| BR (1) | BR112014008944B1 (fr) |
| CL (1) | CL2014000759A1 (fr) |
| ES (1) | ES2601891T3 (fr) |
| IN (1) | IN2014DN01468A (fr) |
| MX (1) | MX350435B (fr) |
| MY (1) | MY170185A (fr) |
| PL (1) | PL2775852T3 (fr) |
| PT (1) | PT2775852T (fr) |
| RU (1) | RU2607458C2 (fr) |
| WO (1) | WO2013057049A1 (fr) |
| ZA (1) | ZA201403591B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2767043C (fr) | 2009-07-06 | 2020-07-14 | Children's Hospital Medical Center | Inhibition de l'inflammation par des oligosaccharides du lait |
| ES2795665T3 (es) | 2012-09-14 | 2020-11-24 | Abbott Lab | Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa |
| DK2708145T3 (en) | 2012-09-14 | 2016-07-18 | Abbott Lab | Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals |
| EP2880993A1 (fr) * | 2013-12-04 | 2015-06-10 | Abbott Laboratories | Procédé permettant d'obtenir une amélioration de l'apprentissage et de la mémoire par l'administration d'acide sialique |
| CN105899089A (zh) * | 2013-12-19 | 2016-08-24 | 雀巢产品技术援助有限公司 | 用于减少婴儿代谢应激、降低肠道通透性和接近母乳喂养婴儿的生长速度的营养组合物 |
| US20150305385A1 (en) * | 2014-04-25 | 2015-10-29 | Mead Johnson Nutrition Company | Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics |
| FR3020949B1 (fr) * | 2014-05-16 | 2018-02-09 | Ecole Normale Superieure De Lyon | Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition |
| MX2017005561A (es) | 2014-10-31 | 2017-06-23 | Nestec Sa | Composicion que comprende oligosacaridos dependientes de fut2 y lacto-n-neotetraosa para usar en la promocion del desarrollo del cerebro y de la cognicion. |
| EP3223826A1 (fr) * | 2014-11-26 | 2017-10-04 | Abbott Laboratories | Formule pour nourrisson contenant du rrr-alpha-tocophérol, du 2'-fucosyllactose et un probiotique |
| WO2016145628A1 (fr) * | 2015-03-18 | 2016-09-22 | Nestec S.A. | Composition comprenant du sialyllactose destinée à être utilisée pour améliorer les capacités d'apprentissage et la fonction mnésique |
| WO2016176484A1 (fr) | 2015-04-28 | 2016-11-03 | Children's Hospital Medical Center | Utilisation de compositions d'oligosaccharides pour améliorer la prise de poids |
| US20180220690A1 (en) * | 2015-08-04 | 2018-08-09 | Nestec S.A. | Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants |
| US11957148B2 (en) * | 2015-12-15 | 2024-04-16 | Societe Des Produits Nestle S.A. | Mixture of human milk oligosaccharides(HMOs) |
| EP3407892A1 (fr) * | 2016-01-26 | 2018-12-05 | Nestec S.A. | Compositions comprenant des oligosaccharides sialylés pour utilisation chez les nourrissons ou les enfants en bas âge à des fins de prévention de l'obésité ou des comorbidités associées survenant plus tard dans la vie et pour favoriser une bonne croissance |
| US10609945B2 (en) | 2016-01-26 | 2020-04-07 | Societe Des Produits Nestle S.A. | Compositions comprising 2FL and LNnT to control food intake and growth in infants or young children |
| CA3020578A1 (fr) * | 2016-04-13 | 2017-10-19 | Meiji Co., Ltd. | Composition d'amelioration de la fonction cerebrale pour nouveau-nes |
| MX2019000881A (es) | 2016-07-28 | 2019-07-01 | Fonterra Cooperative Group Ltd | Producto lacteo y proceso. |
| KR20200003366A (ko) | 2017-05-04 | 2020-01-09 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 신경발달-촉진 식품 조성물 및 이와 관련된 키트, 시스템 및 방법 |
| AU2018272156B2 (en) | 2017-05-24 | 2024-05-30 | Societe Des Produits Nestle S.A. | A nutritional composition for use to enhance attention and/or reduce impulsivity |
| WO2019008105A1 (fr) * | 2017-07-07 | 2019-01-10 | Nestec S.A. | Fortifiants de lait humain |
| US20200305488A1 (en) * | 2017-07-07 | 2020-10-01 | Societe Des Produitis Nestle S.A. | Human milk fortifier |
| RU2698564C1 (ru) * | 2019-01-09 | 2019-08-28 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) | Способ прогнозирования риска развития гипотрофии у детей, родившихся в сроке сверхранних преждевременных родов, к скорригированному возрасту 6 месяцев |
| MX2023005669A (es) | 2020-12-04 | 2023-05-26 | Nestle Sa | Composicion acuosa estable para promover el crecimiento posnatal temprano en infantes prematuros. |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0481038B1 (fr) | 1990-04-16 | 2002-10-02 | The Trustees Of The University Of Pennsylvania | Compositions saccharides et procedes et appareil servant a les synthetiser |
| US5545553A (en) | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US20040048926A1 (en) * | 2002-03-15 | 2004-03-11 | Hoffman Dennis Robert | Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months |
| PL1638414T3 (pl) * | 2003-06-23 | 2009-12-31 | Nestec Sa | Mleko modyfikowane niemowlęce lub następne |
| US8394370B2 (en) * | 2003-06-23 | 2013-03-12 | Nestec S.A. | Nutritional formula for optimal gut barrier function |
| ATE360682T1 (de) * | 2003-06-30 | 2007-05-15 | Clasado Inc | Neue galactooligosaccharidzusammensetzung und herstellung davon |
| US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
| DE602007006635D1 (en) | 2006-02-10 | 2010-07-01 | Nestec Sa | Oligosaccharidmischung |
| BRPI0708689A2 (pt) | 2006-03-07 | 2011-06-07 | Nestec Sa | mistura simbiótica |
| US20080003330A1 (en) | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
| MX348901B (es) * | 2007-11-26 | 2017-07-03 | Nestec Sa | Sistema nutricional adaptado a la edad para infantes. |
| JP2012522827A (ja) | 2009-04-07 | 2012-09-27 | グリコム・アクティーゼルスカブ | ２’−ｏ−フコシルラクトースの合成方法 |
| EP2251030A1 (fr) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrine et santé mentale et développement chez les enfants |
| EP2258218A1 (fr) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Composition nutritionnelle pour supporter le développement cérébral et fonction des tout-petits |
| EP2258216A1 (fr) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Composition nutritionnelle pour supporter le développement cérébral et fonction des tout-petits |
| US20120121562A1 (en) * | 2009-07-31 | 2012-05-17 | Nestec S.A. | Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients |
| CN105330705A (zh) * | 2010-02-19 | 2016-02-17 | 格礼卡姆股份公司 | 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法 |
| EP2404507A1 (fr) | 2010-07-08 | 2012-01-11 | Nestec S.A. | Gamme de laits artificiels adaptés à l'âge avec une teneur optimale en matières grasses |
| AU2011370626A1 (en) * | 2011-06-08 | 2013-11-28 | Nestec S.A. | Nutritional compositions having exogenous milk fat globule membrane components |
-
2012
- 2012-10-12 ES ES12772784.0T patent/ES2601891T3/es active Active
- 2012-10-12 MY MYPI2014700417A patent/MY170185A/en unknown
- 2012-10-12 US US14/352,236 patent/US20140271562A1/en not_active Abandoned
- 2012-10-12 MX MX2014004716A patent/MX350435B/es active IP Right Grant
- 2012-10-12 AU AU2012325060A patent/AU2012325060B2/en not_active Withdrawn - After Issue
- 2012-10-12 EP EP16174616.9A patent/EP3095331A1/fr not_active Withdrawn
- 2012-10-12 PT PT127727840T patent/PT2775852T/pt unknown
- 2012-10-12 IN IN1468DEN2014 patent/IN2014DN01468A/en unknown
- 2012-10-12 PL PL12772784T patent/PL2775852T3/pl unknown
- 2012-10-12 CN CN201280051291.6A patent/CN103889238B/zh active Active
- 2012-10-12 BR BR112014008944-2A patent/BR112014008944B1/pt active IP Right Grant
- 2012-10-12 EP EP12772784.0A patent/EP2775852B1/fr active Active
- 2012-10-12 RU RU2014119844A patent/RU2607458C2/ru active
- 2012-10-12 WO PCT/EP2012/070281 patent/WO2013057049A1/fr active Application Filing
-
2014
- 2014-03-27 CL CL2014000759A patent/CL2014000759A1/es unknown
- 2014-05-16 ZA ZA2014/03591A patent/ZA201403591B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013057049A1 (fr) | 2013-04-25 |
| EP2775852A1 (fr) | 2014-09-17 |
| MY170185A (en) | 2019-07-09 |
| RU2014119844A (ru) | 2015-11-27 |
| PT2775852T (pt) | 2016-11-08 |
| PL2775852T3 (pl) | 2017-02-28 |
| ZA201403591B (en) | 2016-01-27 |
| MX2014004716A (es) | 2015-02-05 |
| MX350435B (es) | 2017-09-06 |
| EP2775852B1 (fr) | 2016-08-17 |
| RU2607458C2 (ru) | 2017-01-10 |
| CL2014000759A1 (es) | 2014-08-22 |
| ES2601891T3 (es) | 2017-02-16 |
| AU2012325060B2 (en) | 2015-11-19 |
| EP3095331A1 (fr) | 2016-11-23 |
| BR112014008944A2 (pt) | 2017-05-02 |
| US20140271562A1 (en) | 2014-09-18 |
| CN103889238A (zh) | 2014-06-25 |
| BR112014008944B1 (pt) | 2020-09-15 |
| AU2012325060A1 (en) | 2014-03-13 |
| CN103889238B (zh) | 2017-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN01468A (fr) | ||
| MX2014004719A (es) | Composicion para su uso en la promocion de la angiogenesis intestinal y de la absorcion de nutrientes y de tolerancia a la alimentacion enteral y/o en la prevencion y/o en el tratamiento de la inflamacion intestinal y/o en la recuperacion posterior a un daño o cirugia intestinal. | |
| PL2547216T3 (pl) | Żywienie niemowląt dla poprawy kompozycji kwasów tłuszczowych błon mózgowych | |
| MY173726A (en) | Synbiotics combination for brain improvement | |
| PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| MX2014004722A (es) | Composicion para ser usada en la promocion del crecimiento de hueso sano y/o en la prevencion y/o tratamiento de la enfermedad osea. | |
| MX2013011835A (es) | Composiciones nutricionales que incluyen acidos grasos de cadena ramificada para la curacion de heridas. | |
| NZ613165A (en) | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof | |
| ZA201502764B (en) | Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof | |
| PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| PH12017500387A1 (en) | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition | |
| MX2015007584A (es) | Triheptanoina para el tratamiento de la deficiencia del transportador de glucosa 1. | |
| BR112012023328A2 (pt) | composições nutricionais | |
| WO2013049519A3 (fr) | Compositions, kits et méthodes de supplémentation alimentaire avec des acides gras à douze atomes de carbone et des acylglycérols à douze atomes de carbone | |
| MX354727B (es) | Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio. | |
| MX2013013512A (es) | Alimento medico para deterioro cognitivo. | |
| PH12016500690A1 (en) | Probiotic stabilization | |
| MX347541B (es) | Analogos de acido sialico. | |
| WO2011088209A3 (fr) | Analogues 1-désoxy de composés apparentés à la vitamine d | |
| NZ626540A (en) | Glutamine enriched nutritional composition for preterm infants | |
| MX2013015419A (es) | Dha y epa en la reduccion de estres oxidante. | |
| PH12014501569A1 (en) | Glutamine enriched nutritional composition for preterm infants | |
| MX2015013179A (es) | Formula infantil con bajo contenido calorico que contiene acido beta-hidroxi-beta-metilbutirico. | |
| MX358142B (es) | Formulaciones y usos del derivado del ácido 2 - hidroxi -5 - fenilazobenzóico para el tratamiento de varones. | |
| GB201209344D0 (en) | Omega-6 enriched pufa phospholipids |